The Redemptive Therapy Institute is committed to confronting the mental health crisis head-on.
We have seen too many friends, family, and community members suffer or die needlessly from mental illness or addiction—because they couldn’t get the support or treatment they deserved.
We believe trauma-informed, psychedelic-assisted therapy shows real promise. And given the growing mental health crisis and lack of effective therapies, we believe it is imperative to allow individuals suffering from mental illness to try these new treatments in a safe, controlled setting.
The Redemptive Therapy Institute will contribute to the growing body of scientific research that aims to identify safe and effective psychedelic therapies for particular mental illnesses. We will also explore how to best translate effective therapies into clinical practice.
Ultimately, our long term goal is to provide evidence-based therapy to all those who need it, regardless of socioeconomic status.
Board of Directors
Bryan Anker, MD
Bryan Anker, MD is the president and co-founder of the Redemptive Therapy Institute. He is a board-certified family medicine physician and currently practices primary care and addiction medicine. As a family physician, he sees, first-hand, the terrible toll mental illness takes on the bodies and minds of his patients. And like most, he has experienced mental illness and addiction among his friends, family, and loved ones.
After attending Boston University School of Medicine, Bryan did his residency training at the University of Michigan. As a National Health Service Corps Scholar, he received a full scholarship to attend medical school. He is committed to working with underserved patient populations and has published peer-reviewed studies in the fields of organic chemistry, infectious disease, and social determinants of health.
Michael Weinstein is the president of AIDS Healthcare Foundation (AHF), the largest global AIDS organization. Before becoming involved in HIV/AIDS-related issues in the 1980s, he was a businessman and graphic designer. Since 1986, Mr. Weinstein has been a leader in the fight against HIV and AIDS. As president and co-founder of AHF, he oversees a multi-billion dollar organization whose mission is to provide “cutting-edge medicine and advocacy regardless of ability to pay.” AHF currently serves over 1.5 million clients in the United States, Africa, Latin America and the Caribbean, the Asia/Pacific region, and Eastern Europe.
Under Weinstein’s leadership, AHF has grown from a group of friends dedicated to the creation of dignified care for people in the last stages of AIDS to the largest AIDS organization in the United States. The Foundation now operates in over 730 treatment clinics in more than 45 countries globally: over 68 outpatient AHF Healthcare Centers in over 16 states as well as in the District of Columbia and Puerto Rico. AHF also operates more than 60 pharmacies in over 17 states and also operates a clinical research unit. Under its Positive Healthcare brand, AHF operates managed care programs for people living with HIV and/or AIDS in California, Florida, and Georgia.
Arvin Garg, MD, MPH, is Professor of Pediatrics and Vice Chair of Health Equity at University of Massachusetts (UMass) Medical School and UMass Memorial Children’s Medical Center. Dr. Garg is also Associate Editor for the Journal of Developmental and Behavioral Pediatrics.
Dr. Garg received his B.A. in Behavioral Biology from Johns Hopkins University, M.P.H from Boston University School of Public Health and his medical doctorate from Boston University School of Medicine. After completing his clinical residency in pediatrics at the University of Connecticut, he worked for two years in private practice in Pennsylvania. He subsequently completed a post-doctoral General Academic Pediatric fellowship at Johns Hopkins University School of Medicine.
Dr. Garg first faculty position was at Floating Hospital for Children at Tufts Medical Center, and prior to joining UMass, Dr. Garg was at Boston Medical Center and Boston University School of Medicine for ten years. Dr. Garg has been recognized for his clinical teaching with awards from Tufts University School of Medicine, Boston University School of Medicine, and the Boston Combined Residency Program.
Dr. Garg’s research focuses on addressing adverse social determinants of health (SDoH) within the delivery of pediatric care, particularly for low-income families, and has been cited in professional guidelines. During fellowship, Dr. Garg’s SDoH trial received both The Francis F. Schwentker Award Winner for Excellence in Research by House Staff and Fellows in the Department of Pediatrics at Johns Hopkins School of Medicine and The Society of Pediatric Research Fellow Clinical Research Award. Since 2009, Dr. Garg has been continuously funded by the NIH and has received extramural funding from private foundations. He currently holds two R01 awards and has published over 70 publications.
Dr. Garg served as the co-chair for the Serving the Underserved Special Interest Group (SIG) for the Academic Pediatric Association (APA) and was a member of the APA Task Force on Childhood Poverty. He was recently the Chair of the Health Care Delivery Committee for the APA. He has also served on various other committees focused on social determinants and community health, both locally and nationally.
See where we are going and how we plan to get there.
Read about our past, current, and future clinical trials.